Touchstone International Medical Science Co Ltd (688013) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Touchstone International Medical Science Co Ltd (688013) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥27.05 Million ≈ $3.96 Million USD) by net assets (CN¥599.62 Million ≈ $87.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688013 market cap for the company's overall valuation and market capitalisation.

Touchstone International Medical Science Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Touchstone International Medical Science Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Touchstone International Medical Science Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Touchstone International Medical Science Co Ltd ranked by their cash flow conversion efficiency. Explore Touchstone International Medical Science cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Is Finansal Kiralama AS
IS:ISFIN
-0.257x
Heung-A Shipping Co. Ltd.
KO:003280
0.034x
Shanghai Hile Bio-tech
SHG:603718
-0.001x
Hunan Zhenghong Science and Technology Develop Co Ltd
SHE:000702
-0.064x
Samji Electronics Co. Ltd
KQ:037460
-0.033x
Taiwan Hopax Chemsistry MFG Co Ltd
TWO:6509
0.035x
Seneca Foods Corp B
NASDAQ:SENEB
0.044x
Hypothekarbank Lenzburg AG
SW:HBLN
-0.426x

Annual Cash Flow Conversion Efficiency for Touchstone International Medical Science Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Touchstone International Medical Science Co Ltd from 2017 to 2024. View Touchstone International Medical Science (688013) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥581.43 Million
≈ $85.08 Million
CN¥53.41 Million
≈ $7.82 Million
0.092x -36.71%
2023-12-31 CN¥571.52 Million
≈ $83.63 Million
CN¥82.95 Million
≈ $12.14 Million
0.145x +46.40%
2022-12-31 CN¥508.41 Million
≈ $74.40 Million
CN¥50.40 Million
≈ $7.38 Million
0.099x -16.74%
2021-12-31 CN¥512.13 Million
≈ $74.94 Million
CN¥60.98 Million
≈ $8.92 Million
0.119x +31.82%
2020-12-31 CN¥465.89 Million
≈ $68.17 Million
CN¥42.08 Million
≈ $6.16 Million
0.090x -72.20%
2019-12-31 CN¥107.18 Million
≈ $15.68 Million
CN¥34.82 Million
≈ $5.10 Million
0.325x -21.80%
2018-12-31 CN¥82.90 Million
≈ $12.13 Million
CN¥34.44 Million
≈ $5.04 Million
0.415x +320.71%
2017-12-31 CN¥79.84 Million
≈ $11.68 Million
CN¥7.88 Million
≈ $1.15 Million
0.099x --

About Touchstone International Medical Science Co Ltd

SHG:688013 China Medical Instruments & Supplies
Market Cap
$293.33 Million
CN¥2.00 Billion CNY
Market Cap Rank
#15086 Global
#4505 in China
Share Price
CN¥24.70
Change (1 day)
+4.31%
52-Week Range
CN¥21.96 - CN¥61.29
All Time High
CN¥67.25
About

Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and re… Read more